Stephen A. Strickland, MD, MSCI - The Oncology Team and Secondary AML: Conversations on New Science and Its Effect on Patient Care

31:09
 
Share
 

Manage episode 242965999 series 1058605
By PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Go online to PeerView.com/ZVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a hematologist/oncologist and a nurse professional discuss the characteristics and management of secondary AML, with an emphasis on practical aspects of care and the use of novel therapy. This multidisciplinary panel also features commentary from a patient with secondary AML and discusses the patient’s experience of a secondary AML diagnosis and subsequent therapeutic journey. Upon completion of this activity, participants should be better able to: Cite the clinical features and therapeutic challenges associated with secondary AML, Recommend novel treatment strategies for patients with secondary AML who are able to receive intensive therapy and/or are eligible for HCT, Identify opportunities for multidisciplinary collaboration with other oncology team members when managing secondary AML, Educate patients about the risks and benefits of novel treatment strategies for secondary AML in the context of a collaborative oncology team.

208 episodes